ATE247959T1 - Nicht peptidische g-csf mimetika - Google Patents

Nicht peptidische g-csf mimetika

Info

Publication number
ATE247959T1
ATE247959T1 AT97928663T AT97928663T ATE247959T1 AT E247959 T1 ATE247959 T1 AT E247959T1 AT 97928663 T AT97928663 T AT 97928663T AT 97928663 T AT97928663 T AT 97928663T AT E247959 T1 ATE247959 T1 AT E247959T1
Authority
AT
Austria
Prior art keywords
pct
compounds
peptidic
csf mimetics
date nov
Prior art date
Application number
AT97928663T
Other languages
English (en)
Inventor
Juan I Luengo
James A Chan
Ann L Breen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE247959T1 publication Critical patent/ATE247959T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97928663T 1996-05-22 1997-05-22 Nicht peptidische g-csf mimetika ATE247959T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1954296P 1996-05-22 1996-05-22
PCT/US1997/008864 WO1997044033A1 (en) 1996-05-22 1997-05-22 Non-peptide g-csf mimetics

Publications (1)

Publication Number Publication Date
ATE247959T1 true ATE247959T1 (de) 2003-09-15

Family

ID=21793762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97928663T ATE247959T1 (de) 1996-05-22 1997-05-22 Nicht peptidische g-csf mimetika

Country Status (17)

Country Link
US (1) US5981551A (de)
EP (1) EP0920314B1 (de)
JP (1) JP2000512629A (de)
KR (1) KR20000015881A (de)
AT (1) ATE247959T1 (de)
AU (1) AU722453B2 (de)
BR (1) BR9709326A (de)
CA (1) CA2255731A1 (de)
CZ (1) CZ376798A3 (de)
DE (1) DE69724438T2 (de)
ES (1) ES2205239T3 (de)
IL (1) IL127065A0 (de)
NO (1) NO985406D0 (de)
NZ (1) NZ332823A (de)
PL (1) PL330148A1 (de)
TR (1) TR199802401T2 (de)
WO (1) WO1997044033A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US6211200B1 (en) * 1997-10-31 2001-04-03 Smithkline Beecham Corporation Metal complexes
US20010016568A1 (en) * 1997-10-31 2001-08-23 Juan I. Luengo Novel metal complexes
CA2328252A1 (en) * 1998-04-14 1999-10-21 Katherine Louisa Widdowson Receptor ligands
TWI242563B (en) * 1998-04-30 2005-11-01 Tanox Inc Monoclonal agonist antibodies which specifically bind to or interact with human G-CSF receptor
US6346531B1 (en) 1998-05-22 2002-02-12 Smithkline Beecham Corporation G-CSF mimetics
US6630470B1 (en) * 1998-05-22 2003-10-07 Smithkline Beecham Corporation G-CSF mimetics
JP2002167378A (ja) 2000-09-22 2002-06-11 Ss Pharmaceut Co Ltd イミダゾール誘導体又はその塩
US20050084908A1 (en) * 2000-11-06 2005-04-21 Chugai Seiyaku Kabushiki Kaisha Methods for detecting binding of low-molecular-weight compound and its binding partner molecule
US20020177321A1 (en) * 2001-03-30 2002-11-28 Li Si Yi Plasma etching of silicon carbide
US7084070B1 (en) 2001-03-30 2006-08-01 Lam Research Corporation Treatment for corrosion in substrate processing
US7638536B2 (en) 2002-01-18 2009-12-29 Astellas Pharma Inc. 2-Acylaminothiazole derivative or salt thereof
JP2006347882A (ja) * 2003-09-02 2006-12-28 Ss Pharmaceut Co Ltd ベンジルアルコール誘導体又はその塩
US20090226397A1 (en) * 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
EP2198876B1 (de) 2003-10-24 2012-12-05 Nora Therapeutics, Inc. Verfahren zur Reduzierung der Wahrscheinlichkeit des Implantationsversagens bei einer Person
US8338373B2 (en) * 2003-10-24 2012-12-25 Nora Therapeutics, Inc. Method for reducing the risk of spontaneous abortion in a human female subject
CN102223893B (zh) 2008-07-22 2014-07-16 曼诺吉尼克斯公司 治疗与绝经、激素改变和关节炎相关的症状的组合物和方法
US9151289B2 (en) 2008-08-21 2015-10-06 Cummins Inc. Fuel pump
CZ302068B6 (cs) * 2009-07-28 2010-09-22 Univerzita Pardubice Zpusob prípravy cis-1,3,4,6-tetranitrooktahydroimidazo-[4,5-d]imidazolu
WO2015057724A1 (en) 2013-10-14 2015-04-23 Nora Therapeutics, Inc. Use of g-csf for treating or preventing villitis of unknown etiology in a human female

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2596126A (en) * 1943-02-24 1952-05-13 Homer W Carhart Method for separating diaryl-2-imino hydantoins from the corresponding 2,5-di-imino glycolurils
JPS4995992A (de) * 1973-01-27 1974-09-11
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor

Also Published As

Publication number Publication date
EP0920314A4 (de) 2001-08-16
WO1997044033A1 (en) 1997-11-27
DE69724438T2 (de) 2004-06-09
CA2255731A1 (en) 1997-11-27
NZ332823A (en) 2000-05-26
AU722453B2 (en) 2000-08-03
DE69724438D1 (de) 2003-10-02
IL127065A0 (en) 1999-09-22
JP2000512629A (ja) 2000-09-26
PL330148A1 (en) 1999-04-26
EP0920314A1 (de) 1999-06-09
KR20000015881A (ko) 2000-03-15
TR199802401T2 (xx) 1999-03-22
AU3286597A (en) 1997-12-09
BR9709326A (pt) 1999-08-10
US5981551A (en) 1999-11-09
CZ376798A3 (cs) 1999-04-14
NO985406L (no) 1998-11-20
EP0920314B1 (de) 2003-08-27
NO985406D0 (no) 1998-11-20
ES2205239T3 (es) 2004-05-01

Similar Documents

Publication Publication Date Title
DE69724438D1 (de) Nicht peptidische g-csf mimetika
DE69918422D1 (de) Phthalazinone pde iii/iv hemmer
NZ290420A (en) Phenyl or pyridyl-amide substituted dihydro benzofurans; medicaments
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
DE69622031D1 (de) INDOLDERIVATE ALS cGMP-PDE INHIBITOREN
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
CA2297911A1 (en) Substituted 6-phenylphenanthridines
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
ZA918331B (en) Antimicrobial agents as well as substituted 2-cyclohexan-1-yl-amine derivatives and their preparation
BG103947A (en) Derivatives of 9-oxymerythromycin
IL133824A (en) Tetrazole derivatives and medicaments containing the same
IL136359A0 (en) Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same
AP9801377A0 (en) Tricyclic erythromycin derivatives.
IL114968A (en) 1,4-dihydropyridine compounds and pharmaceutical compositions containing them
RU94022663A (ru) Производные 2-меркаптобензимидазола, обладающие селективной анксиолитической активностью
AP9801235A0 (en) Erythromycin derivatives.
NZ331374A (en) Phenanthridine compounds and pharmaceutical compositions thereof
AU758194C (en) Novel benzimidazoles and benzoxazoles

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties